Resultats - Rehues Masip, Pere
Rehues Masip, Pere
| Tesis Doctorals Dirigides / Theses |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Publicacions en Revista / Papers |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Títol: NMR-based metabolomic profiling identifies inflammation and muscle-related metabolites as predictors of incident type 2 diabetes mellitus beyond glucose: the Di@bet |
| Autors: Ozcariz, E; Guardiola, M; Amigó, N; Rojo-Martínez, G; Valdés, S; Rehues, P; Masana, L; Ribalta, J |
| Any: 2023 Clau: Article |
| Revista: Diabetes Research And Clinical Practice |
| País: N/D |
| Títol: PCSK9 Inhibitors Have Apolipoprotein C-III-Related Anti-Inflammatory Activity, Assessed by 1H-NMR Glycoprotein Profile in Subjects at High or very High Cardiovascular Risk |
| Autors: Rehues, P; Girona, J; Guardiola, M; Plana, N; Scicali, R; Piro, S; Muñiz-Grijalvo, O; Díaz-Díaz, JL; Recasens, L; Pinyol, M; Rosales, R; Esteban, Y; Amigó, N; Masana, L; Ibarretxe, D; Ribalta, J |
| Any: 2023 Clau: Article |
| Revista: International Journal Of Molecular Sciences |
| País: N/D |
| Títol: Characterization of the lps and 3ohfa contents in the lipoprotein fractions and lipoprotein particles of healthy men |
| Autors: Rehues, P; Rodríguez, M; Alvarez, J; Jiménez, M; Melià, A; Sempere, M; Balsells, C; Castillejo, G; Guardiola, M; Castro, A; Ribalta, J |
| Any: 2022 Clau: Article |
| Revista: Biomolecules |
| País: N/D |
| Títol: Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects |
| Autors: Rodríguez M; Rehues P; Iranzo V; Mora J; Balsells C; Guardiola M; Ribalta J |
| Any: 2022 Clau: Article |
| Revista: Journal Of Proteomics |
| País: N/D |
| Llibres / Books |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Capítols de Llibre / Book chapters |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Altres Documents / Other documents |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Patents Sol.licitades / Patents |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
| Congressos / Conferences |
| 2019 | 2020 | 2021 | 2022 | 2023 |
|---|
